FDA Panel Rejects Pravastatin/Aspirin Combo. Bristol-Myers-Squibb made a play for this comibation to maintain a market share for pravachol … which will go generic soon. Nice try.
FDA Panel Rejects Pravastatin/Aspirin Combo.
Published
Health, Technology, Family Medicine and other observations – since 1999